Salute e Benessere

PRODUCTLIFE GROUP ACQUIRES INTEXO SOCIETA BENEFIT, STRENGTHENING ITS MARKET…

Founded in 1976, Intexo Società Benefit provides clients with an integrated market access and regulatory affairs offering covering access strategies, market and payer research, health economics evaluations, patient advocacy, negotiations and contracting, pricing and reimbursement as well as strategic regulatory. The group specializes in highly innovative products, including oncology, orphan drugs and advanced therapeutic medicinal products (ATMPs). Founded in 1976, Intexo Società Benefit...
PR Newswire
17/10/2023

Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in…

Excessive deposition of C3 breakdown products in the kidney lead to inflammation and damage of the kidney, often causing kidney failure. Excessive deposition of C3 breakdown products in the kidney lead to inflammation and damage of the kidney, often causing kidney failure. "In as early as 12 weeks, these positive results show that pegcetacoplan has the capacity to clear the deposits that are causing kidney damage and may block future damage from occurring," saidAndrew Bomback, M.D...
PR Newswire
17/10/2023

AC Immune Announces Upcoming Presentations at the 16th CTAD Conference

AC Immune Announces Upcoming Presentations at the 16 thCTAD ConferenceLausanne, Switzerland, October 17, 2023– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the 16 thClinical Trials on Alzheimer's Disease (CTAD) Conference, taking place in Boston, USA, on October 24-27, 2023. Abeta targeted immunotherapy...
Nasdaq GlobeNewswire
17/10/2023

Antion Biosciences Announces Presentation of Two Abstracts from its Multiplex…

Functional demonstration of Antion's uniquely capable technology to develop allogeneic anti-CD19 CAR T-cells with “tuned” silencing of HLA-I Latest advancements in the application of Antion's miCAR platform to multiplex engineer allogeneic and hypoimmunogenic CAR T-cells with enhanced cellular potency by means of 6-target gene silencingGENEVA, Oct.17, 2023(GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is...
Nasdaq GlobeNewswire
17/10/2023

Novo Nordisk honored as one of the best companies to work in Kuwait, Qatar…

In a statement from Venkat Kalyan, Vice President and General Manager of Novo Nordisk Gulf Cluster, he said "This certificate showcased our dedication to creating a workplace that values and supports our talented team members. This achievement reflects the extraordinary commitment we have demonstrated in cultivating a positive workplace culture and nurturing a supportive community. It also embeds our diversity and inclusion mindset. This remarkable achievement is a testament to the…
PR Newswire
17/10/2023

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023

Company Announcement Net sales of DARZALEX ®in the third quarter of 2023 totaled USD 2,499 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; October 17, 2023 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ®(daratumumab), including sales of the subcutaneous (SC) product (daratumumab and hyaluronidase-fihj , sold under the tradename DARZALEXFASPRO® ...
Nasdaq GlobeNewswire
17/10/2023

Global Advanced Drug Delivery Market Set to Surge, Reaching USD 137.33 Billion…

Advanced Drug Delivery: Revolutionizing Medicine Advanced Drug Delivery: Revolutionizing Medicine The term "advanced drug delivery" encompasses the techniques, formulations, and methods employed to administer drugs for various therapeutic purposes. It represents the precise delivery of medication particles to their intended destinations, often within nerves or cells. Advanced drug delivery systems are designed to administer drugs in a controlled or modified manner, resulting in safer…
PR Newswire
17/10/2023

Global AI in Healthcare Market to Reach USD 152.50 Billion by 2030, Fueled by…

Revolutionizing Healthcare Through Artificial Intelligence Revolutionizing Healthcare Through Artificial Intelligence Artificial Intelligence (AI) in healthcare harnesses advanced computational algorithms and machine learning techniques to decipher complex medical data, enabling profound transformations in the healthcare sector. The applications of AI are vast and impactful, ranging from disease diagnosis and detection to personalized treatment, drug discovery, telemedicine, and more...
PR Newswire
17/10/2023

AI-Enabled Imaging Solutions Market to Reach USD 10912.78 Million by 2030…

Revolutionizing Medical Imaging Through AI Revolutionizing Medical Imaging Through AI AI-enabled Medical Imaging Solutions represent an innovative healthcare technology that incorporates Artificial Intelligence (AI) algorithms and machine learning techniques to revolutionize the acquisition, analysis, interpretation, and management of medical images. These cutting-edge solutions provide invaluable assistance to healthcare professionals, especially radiologists and clinicians, across...
PR Newswire
17/10/2023

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

SHL and Lifecore will, pursuant to the terms of its agreement, exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development. SHL and Lifecore will, pursuant to the terms of its agreement, exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and...
PR Newswire
17/10/2023

[Kyoto Asanoha］A challenge from Japan with strict cannabis regulations -…

Kyoto Asanoha will be showcasing an innovative relaxation product from Japan's oldest capital city, Kyoto: the scented hemp Kyo Sensu, a fan made of hemp. Kyoto Asanoha will be showcasing an innovative relaxation product fromJapan'soldest capital city,Kyoto : the scented hemp Kyo Sensu, a fan made of hemp. Folding Fan (in Japanese name 'Sensu') The fan is a traditional handicraft that originated inJapanaround 1,200 years ago, and is highly valued as a decorative item as well...
PR Newswire
17/10/2023

Aidoc Expands its Partnership with GLEAMER to Enhance its Chest Imaging AI Suite

With this expanded partnership, Aidoc firmly establishes itself as the exclusive platform provider of a complete AI suite for chest imaging across both CT and X-ray. These advanced capabilities are powered by Aidoc's award-winning aiOS platform, which seamlessly integrates into the existing IT infrastructure within healthcare organisations, enabling the implementation of AI at scale. Aidoc's AI offering in the chest imaging space is complimented by its EMR-integrated patient follow-up tools…
PR Newswire
17/10/2023

SKF confirms closure of Luton factory

David Johansson, President, Industrial Region Europe Middle East and Africa, says: "Following a comprehensive consultation process, the parties have confirmed that no viable alternative to closing the Luton factory has been found. As we move forward, we are committed to ensuring full support and assistance is provided to all those affected. On behalf of the full management team of SKF, I want to thank all our employees in Luton for their many years of commitment and dedication."…
PR Newswire
17/10/2023

STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the…

The presentation entitled "STC-15, a small molecule inhibitor of the RNA methyltransferase METTL3, activates anti-tumor immunity and reshapes the tumor microenvironment" detailed pre-clinical findings from STORM's investigational drug STC-15 in combination with DNA damaging therapies. STC-15 is an orally bioavailable, highly selective METTL3 inhibitor and is the first molecule specifically targeting an RNA methyltransferase enzyme to enter clinical development. The presentation…
PR Newswire
17/10/2023

Diamyd Medical announces a webcast presentation on October 20 regarding its…

The presentation is hosted by News Agency Direkt and Direkt Studios and can be watched at https://www.youtube.com/watchv=mq7DE4kF7hE&ab_channel=DirektStudios. The presentation is hosted by News Agency Direkt and Direkt Studios and can be watched athttps://www.youtube.com/watchv=mq7DE4kF7hE&ab_channel=DirektStudios. About Diamyd MedicalDiamyd Medical develops precision medicine therapies for Type 1 Diabetes. Diamyd ®is an antigen-specific immunotherapy for the preservation of...
PR Newswire
17/10/2023

SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy…

"This research collaboration and license agreement is an exciting opportunity to develop a novel gene therapy in an area of high unmet medical need. We are proud that Spark Therapeutics recognizes the potential of our pioneering Protein Splicing platform and the profound impact it could have in the treatment of inherited retinal diseases that are unable to be effectively addressed by other gene therapy approaches," said, Miquel Vila-Perelló, Ph.D., Chief Executive Officer and…
PR Newswire
17/10/2023

Oncotech AI-powered diagnostic mobile cancer and diabetes screening technology…

The mobile screening technology is used by doctors and patients in Central Africa, where there is huge demand for diabetes and cancer screening plus diagnostics. The Ophtascan™ technology is currently being used by Sigma Africa clinicians in the Central African Republic, Democratic Republic of Congo, Liberia and Tanzania. The mobile screening technology is used by doctors and patients inCentral Africa, where there is huge demand for diabetes and cancer screening plus diagnostics....
PR Newswire
17/10/2023

EAACI Pediatric Allergy and Asthma Meeting 2023: Shaping the Future of Pediatric…

The burden of allergic diseases and asthma in children has seen a substantial rise in recent years due to various factors, including differences in lifestyles, changes in food introduction practices, and increased industrialization. Allergy often manifests as a multi-system disorder in children with co-existing conditions such as allergic rhinitis, eczema, and food allergies. These conditions can significantly impact a child's daily life, affecting their school performance, travel, dietary…
PR Newswire
17/10/2023

Imlifidase demonstrated 90% patient survival and 82% graft survival at five…

The 17-HMedIdeS-14 study included patients who consented to long-term follow-up and had previously received an imlifidase-enabled transplant in Hansa's phase 2 studies. The 5-year extended pooled analysis is a continuation of the analysis at 3-years of crossmatch positive only patients published in the American Journal of Transplantation. Hansa is continuing to analyze the data from 17-HMedIdeS-14 along with the extended pooled analysis and plans to share further data in 2024. The...
PR Newswire
17/10/2023

Basilea reports new data for ceftobiprole (Zevtera®) presented at US IDWeek…

Eight presentations on antibiotic ceftobiprole providing further evidence for its activity against methicillin-resistantStaphylococcus aureus(MRSA) and other clinically relevant pathogensAllschwil, Switzerland, October 17, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that scientific presentations with new data on its...
Nasdaq GlobeNewswire
17/10/2023

Mithra's Board of Directors to propose the removal of its request for change of…

Mithra'sBoardofDirectorstoproposetheremovalofits request for change of the remuneration policy attheSpecialGeneralMeeting Liege, Belgium, 17 October 2023 – 7:00 CEST –Mithra (Euronext Brussels: MITRA) (the “Company”),a company dedicated to Women's Health, announces today that following recommendation from itsNomination and Remuneration Committee, its Board of Directors has unanimously agreed by boardresolution of yesterday to request the removal...
Nasdaq GlobeNewswire
17/10/2023

BioSenic S.A. : Transparency notifications received from François Rieger…

REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, October 17, 2022, 7am CEST – Transparency notifications received from François Rieger, Véronique Pomi, FA Dièse 3 SAS and Capital Grand Est SAS Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, October 17, 2022, 7am CEST –BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company...
Nasdaq GlobeNewswire
17/10/2023

InfiRay® Debuts at Powerexpo Almaty 2023, Kazakhstan

InfiRay® thermal cameras have made a stunning debut, providing systematic solutions for power-related industries. In addition to the C/M/P series handheld thermal cameras with high image quality, the AT1280 will also make a high profile at this expo. As the first InfiRay®thermal camera featuring 1280×1080 HD resolution, the most advanced REAL 1.3-megapixel infrared temperature measurement device will contribute a lot to the future. The 1280×1024 full-frame temperature measurement thermal camera…
PR Newswire
17/10/2023

Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study…

Key Takeaways from the Large Granular Lymphocyte Leukemia Market Report Key Takeaways from the Large Granular Lymphocyte Leukemia Market Report Discover which therapies are expected to grab the major large granular lymphocyte leukemia market share @Large Granular Lymphocyte Leukemia Market Report Large Granular Lymphocyte Leukemia Overview Large granular lymphocytic leukemia (LGLL) is a chronic blood disorder characterized by an elevated count of large granular lymphocytes...
PR Newswire
16/10/2023
Altri  Comunicati